Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Stuart

Showing results (141-150 of 158) with videos related to

Pageof 16
Sort By:
Genes & Development|July 21, 2018
Mutations in microRNA processing genes in Wilms tumors derepress the <i>IGF2</i> regulator <i>PLAG1</i>Kenneth S Chen, Emily K Stroup, Albert Budhipramono, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Stepped-care approach to treating MS: a managed care treatment algorithmSheldon R Rich, Imelda C Coleman, Richard Cook, et al.
The Journal of Infectious Diseases|October 1, 1978
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacteriumS B Thacker, J V Bennett, T F Tsai, et al.
Scientific Reports|April 22, 2017
Low-noise time-resolved optical sensing of electromagnetic pulses from petawatt laser-matter interactionsT S Robinson, F Consoli, S Giltrap, et al.
Applied Optics|February 3, 2016
Multiwavelength interferometry system for the Orion laser facilityS Patankar, E T Gumbrell, T S Robinson, et al.
The New England Journal of Medicine|March 3, 2006
Natalizumab plus interferon beta-1a for relapsing multiple sclerosisRichard A Rudick, William H Stuart, Peter A Calabresi, et al.
Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.
Molecular Cancer Therapeutics|February 28, 2018
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell TumorsKenneth S Chen, Nicholas J Fustino, Abhay A Shukla, et al.
The Review of Scientific Instruments|November 29, 2014
Monochromatic radiography of high energy density physics experiments on the MAGPIE generatorG N Hall, G C Burdiak, L Suttle, et al.
Pageof 16

Showing results (141-150 of 158) with videos related to

Sort By:
Pageof 16
Genes & Development|July 21, 2018
Mutations in microRNA processing genes in Wilms tumors derepress the <i>IGF2</i> regulator <i>PLAG1</i>Kenneth S Chen, Emily K Stroup, Albert Budhipramono, et al.
Journal of Neurology|October 20, 2011
Additional efficacy endpoints from pivotal natalizumab trials in relapsing-remitting MSBianca Weinstock-Guttman, Steven L Galetta, Gavin Giovannoni, et al.
Journal of Managed Care Pharmacy : JMCP|July 16, 2004
Stepped-care approach to treating MS: a managed care treatment algorithmSheldon R Rich, Imelda C Coleman, Richard Cook, et al.
The Journal of Infectious Diseases|October 1, 1978
An outbreak in 1965 of severe respiratory illness caused by the Legionnaires' disease bacteriumS B Thacker, J V Bennett, T F Tsai, et al.
Scientific Reports|April 22, 2017
Low-noise time-resolved optical sensing of electromagnetic pulses from petawatt laser-matter interactionsT S Robinson, F Consoli, S Giltrap, et al.
Applied Optics|February 3, 2016
Multiwavelength interferometry system for the Orion laser facilityS Patankar, E T Gumbrell, T S Robinson, et al.
The New England Journal of Medicine|March 3, 2006
Natalizumab plus interferon beta-1a for relapsing multiple sclerosisRichard A Rudick, William H Stuart, Peter A Calabresi, et al.
Journal of the Neurological Sciences|March 19, 2010
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosisErnst-Wilhelm Radue, William H Stuart, Peter A Calabresi, et al.
Molecular Cancer Therapeutics|February 28, 2018
EGF Receptor and mTORC1 Are Novel Therapeutic Targets in Nonseminomatous Germ Cell TumorsKenneth S Chen, Nicholas J Fustino, Abhay A Shukla, et al.
The Review of Scientific Instruments|November 29, 2014
Monochromatic radiography of high energy density physics experiments on the MAGPIE generatorG N Hall, G C Burdiak, L Suttle, et al.
Pageof 16